Presynaptic cholinergic neuron surface receptors

Presynaptic cholinergic neuron surface receptors are a heterogeneous group of proteins located on the terminal membranes of neurons that release acetylcholine. These receptors, primarily including muscarinic (M2, M4) and nicotinic (α7, α4β2) subtypes, play a critical role in the feedback regulation of neurotransmitter release (StatPearls, 2023). Muscarinic autoreceptors typically provide inhibitory feedback to prevent excessive acetylcholine secretion, while nicotinic heteroreceptors often facilitate release (PubMed, 1997). Dysregulation of these receptors is implicated in various neurological conditions, most notably Alzheimer's disease, where a loss of cholinergic tone contributes to cognitive decline (NIH, 2022). Pharmacological targeting of these receptors aims to enhance cholinergic signaling or, in the case of toxins like Botulinum neurotoxin, to block neuromuscular transmission by preventing vesicle fusion at the presynaptic surface (NCBI, 2017). These receptors are also involved in the modulation of other neurotransmitters, making them key targets for treating cognitive and motor disorders. In the peripheral nervous system, they are essential for neuromuscular junction function and autonomic regulation. Therapeutic strategies often involve selective agonists or antagonists to fine-tune the amount of acetylcholine available in the synaptic cleft.

Other names

Presynaptic cholinergic receptorsCholinergic autoreceptorsPresynaptic muscarinic receptorsPresynaptic nicotinic receptorsPresynaptic ACh receptors

Modulation of acetylcholine release via feedback inhibition (autoreceptors) or facilitation (heteroreceptors); inhibition of synaptic vesicle exocytosis.